Effectiveness of an adaptive, multifaceted intervention to enhance care for patients with complex multimorbidity in general practice: protocol for a pragmatic cluster randomised controlled trial (the MM600 trial)
Anne Holm(University of Copenhagen), Susanne Reventlow(University of Copenhagen), Tora Grauers Willadsen(University of Copenhagen), Sussi Friis Buhl(University of Southern Denmark), John Brodersen(University of Copenhagen), Ann-Kathrin Lindahl Christiansen(University of Copenhagen), Jette Kolding Kristensen(Aalborg University), Frans Boch Waldorff(University of Copenhagen), Maarten Pieter Rozing(Leiden University Medical Center), Volkert Siersma(University of Copenhagen), Anders Prior(Aarhus University), Anna Bernhardt Lyhnebeck(University of Copenhagen), John Sahl Andersen(The University of Texas at San Antonio Health Science Center)
Cited by 7
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
|Annals of Oncology|1996|569
The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round
|Journal of Thoracic Oncology|2009|440
Overdiagnosis: what it is and what it isn’t
|BMJ Evidence-Based Medicine|2018|368